Australia has one of the highest rates of mesothelioma in the world. The deadly disease is caused by exposure to asbestos, which was widely used in Australia for decades. Unfortunately, mesothelioma symptoms do not appear until 20-50 years after asbestos exposure, making early detection incredibly difficult. However, new developments in medical testing offer hope for detecting mesothelioma early on. One such promising test is called Mesobreath 5, which has been developed by researchers in Belgium.

Mesobreath 5 is a non-invasive screening test that detects malignant mesothelioma in people who have been exposed to asbestos dust. The test measures specific markers of mesothelioma in the breath of patients. This breath test could revolutionise the early detection of mesothelioma.

Researchers at the University of Antwerp in Belgium developed Mesobreath 5 as a way to detect latent mesothelioma in patients who have had prior exposure to asbestos. The test is incredibly easy for patients – all they have to do is breathe into a tube, which is then analysed for markers indicative of mesothelioma. If a patient has a positive result, they may be referred for further tests and evaluation. The researchers presented their findings in September 2023 at the World Conference on Lung Cancer in Singapore. The test is still in a phase of testing, and it produces some false positives.  Dr Lamote, the lead researcher, stated that as it is not yet known how far in advance this test could detect mesothelioma, it does not automatically mean that the “false positive” results is a bad thing.  This test requires further study, including testing participants with the false positives to confirm whether they have mesothelioma in the early stages.

One of the major benefits of Mesobreath 5 is its non-invasive nature. Currently, diagnosing mesothelioma involves invasive procedures like biopsies, which can be uncomfortable and carry significant risks. In contrast, Mesobreath 5 is a simple breath test that poses no risk to patients.

The development of Mesobreath 5 is particularly important for Australia, where mesothelioma rates are among the highest in the world. This study may offer a new way to detect latent mesothelioma in individuals who may not yet be exhibiting symptoms. Early detection will allow for prompt treatment and better outcomes for patients.

If you or your loved one suffer from mesothelioma, you might be entitled to claim compensation.  At Turner Freeman, we actively assist workers suffering from asbestos induced illnesses to claim the compensation they are entitled to. We understand the hardship and stress these individuals have suffered due to their illness and take pride in providing support throughout the entire legal process.

If you were exposed to silica dust, to discuss your entitlement in more detail, please contact us as soon as possible on 02 8833 2500 so that we can address any questions or concerns you may have about making a claim.

Like it? Share it!